Literature DB >> 2254217

Multiple mechanisms of erythromycin resistance.

E A Eady1, J I Ross, J H Cove.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2254217     DOI： 10.1093/jac/26.4.461

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN： 0305-7453            Impact factor:   5.790


× No keyword cloud information.
  7 in total

1.  Decreased azithromycin susceptibility of Neisseria gonorrhoeae due to mtrR mutations.

Authors:  L Zarantonelli; G Borthagaray; E H Lee; W M Shafer
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191

2.  Structural and functional characterization of CFE88: evidence that a conserved and essential bacterial protein is a methyltransferase.

Authors:  Keith L Constantine; Stanley R Krystek; Matthew D Healy; Michael L Doyle; Nathan O Siemers; Jane Thanassi; Ning Yan; Dianlin Xie; Valentina Goldfarb; Joseph Yanchunas; Li Tao; Brian A Dougherty; Bennett T Farmer
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

3.  Exposition of a family of RNA m(5)C methyltransferases from searching genomic and proteomic sequences.

Authors:  R Reid; P J Greene; D V Santi
Journal:  Nucleic Acids Res       Date:  1999-08-01       Impact factor: 16.971

Review 4.  Miocamycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential.

Authors:  S M Holliday; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

5.  Inactivation of the macrolide antibiotics erythromycin, midecamycin, and rokitamycin by pathogenic Nocardia species.

Authors:  K Yazawa; Y Mikami; T Sakamoto; Y Ueno; N Morisaki; S Iwasaki; K Furihata
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

6.  Investigation of Staphylococcus aureus isolates identified as erythromycin intermediate by the Vitek-1 System: comparison with results obtained with the Vitek-2 and Phoenix systems.

Authors:  Patrick Tang; Donald E Low; Sandra Atkinson; Karen Pike; Aisha Ashi-Sulaiman; Andrew Simor; Susan Richardson; Barbara M Willey
Journal:  J Clin Microbiol       Date:  2003-10       Impact factor: 5.948

7.  Evaluating approved and alternative treatments against an oxytetracycline-resistant bacterium responsible for European foulbrood disease in honey bees.

Authors:  Fatima Masood; Jenna M Thebeau; Allyssa Cloet; Ivanna V Kozii; Michael W Zabrodski; Sarah Biganski; Jenny Liang; M Marta Guarna; Elemir Simko; Antonio Ruzzini; Sarah C Wood
Journal:  Sci Rep       Date:  2022-04-07       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.